|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆĶô¼¿ ÄÚ¸®¾Æ -CRA
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
10.10 |
|
|
ÀÎÅÍÆÊ |
ÀÎÅÍÆÊ¿¡¼ Á÷¿øÀ» ¸ðÁýÇÕ´Ï´Ù
¼¿ï °¼±¸ | °íµîÇб³ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
»ó½Ãä¿ë |
04.30 |
|
|
¿¡À̽ºÆÄÆ®³Ê½º |
¿Ü±¹°è ¸¶ÄÉÆÃȸ»ç Outcomes research team
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
02.18 |
|
|
(ÁÖ)Çѱ¹ÄÚ·¯½ºÁ¦¾à |
(ÁÖ)Çѱ¹ÄÚ·¯½ºÁ¦¾à ¹ÙÀÌ¿ÀÀǾàÇ° ºÎ¹® ä¿ë ¸ðÁý
°¿ø Ãáõ½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
»ý»ê/»ý»ê°ü¸® |
2³â¡è |
ä¿ë½Ã |
02.26 |
|
|
Çѱ¹ÆúÁÖ½Äȸ»ç |
Sales Representative for medical product
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
»ó½Ãä¿ë |
12.11 |
|
|
ÀÎÀç´åÄÄ |
±Û·Î¹ú Á¦¾à»ç RA °æ·ÂÀÚ Ã¤¿ë
ÀÎõ ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
1³â¡è |
ä¿ë½Ã |
03.24 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆĶô¼¿ ÄÚ¸®¾Æ -CRA
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
09.13 |
|
|
¸ÞµðÈúº´¿ø |
¾à»ç
¼¿ï ¾çõ±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°ø°³Ã¤¿ë |
1³â¡è |
ä¿ë½Ã |
04.28 |
|
|
¿¡À̽ºÆÄÆ®³Ê½º |
¿Ü±¹°è ÀǾà Àü¹® ¸¶ÄÉÆà ¸®¼Ä¡ ȸ»ç ÆÀÀå±Þ ¸ðÁý
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
04.30 |
|
|
ÀÎÆ÷ºê·¹ÀÎ |
Á¦¾à°ü·Ã ´Ù±¹Àû±â¾÷ RA ´ã´çÀÚ (´ë¸®±Þ)
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
12.08 |
|
|
¿¥¾ÆÀÌ¿¡½ºÄÚ¸®¾Æ |
Ä¡°ú¿ë ÀÓÇöõÆ® ¿µ¾÷ °æ·ÂÀÚ ¸ðÁý
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
»ó½Ãä¿ë |
04.09 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆĶô¼¿ ÄÚ¸®¾Æ- Clinical Lead (CPS Department)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
08.22 |
|
|
¾ËÇÇ¿¡½º¸®¼Ä¡ |
¹Ì±¹°è Global CRO Company ÀÇ CRA ä¿ë (for Global Projec
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
»ó½Ãä¿ë |
09.03 |
|
|
(ÁÖ)Àνá¾îÄ¡ÄÁ¼³Æà |
¾à»ç (RA)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
¶óÀ̼¾½ºIn/Out |
4³â¡è |
ä¿ë½Ã |
10.10 |
|
|
¿¥¼Å¬ |
»ó´ã°£È£»ç(¼¿ï,±¤ÁÖ)Ãæ¿ø
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) ÀçÇÐ |
°ø°³Ã¤¿ë |
1³â¡è |
ä¿ë½Ã |
10.07 |
|